542 related articles for article (PubMed ID: 28381441)
1. Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.
Shinohara M; Tachibana M; Kanekiyo T; Bu G
J Lipid Res; 2017 Jul; 58(7):1267-1281. PubMed ID: 28381441
[TBL] [Abstract][Full Text] [Related]
2. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
[TBL] [Abstract][Full Text] [Related]
5. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Storck SE; Pietrzik CU
Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.
Zhao N; Liu CC; Qiao W; Bu G
Biol Psychiatry; 2018 Feb; 83(4):347-357. PubMed ID: 28434655
[TBL] [Abstract][Full Text] [Related]
8. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM
Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319
[TBL] [Abstract][Full Text] [Related]
9. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.
Martiskainen H; Haapasalo A; Kurkinen KM; Pihlajamäki J; Soininen H; Hiltunen M
Expert Opin Ther Targets; 2013 Jul; 17(7):781-94. PubMed ID: 23573918
[TBL] [Abstract][Full Text] [Related]
10. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.
Holtzman DM; Herz J; Bu G
Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a006312. PubMed ID: 22393530
[TBL] [Abstract][Full Text] [Related]
13. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
14. Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1.
Strickland MR; Holtzman DM
J Clin Invest; 2019 Mar; 129(3):969-971. PubMed ID: 30741722
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.
Zlokovic BV; Deane R; Sagare AP; Bell RD; Winkler EA
J Neurochem; 2010 Dec; 115(5):1077-89. PubMed ID: 20854368
[TBL] [Abstract][Full Text] [Related]
16. Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of Alzheimer's disease.
Hu Q; Yu B; Chen Q; Wang Y; Ling Y; Sun S; Shi Y; Zhou C
Mol Med Rep; 2018 Jan; 17(1):827-834. PubMed ID: 29115637
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.
Sagare AP; Deane R; Zlokovic BV
Pharmacol Ther; 2012 Oct; 136(1):94-105. PubMed ID: 22820095
[TBL] [Abstract][Full Text] [Related]
18. Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer's disease: A potential therapeutic target?
Patel P; Shah J
J Chem Neuroanat; 2017 Nov; 85():36-42. PubMed ID: 28669880
[TBL] [Abstract][Full Text] [Related]
19. Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.
Akram A; Schmeidler J; Katsel P; Hof PR; Haroutunian V
Neurobiol Aging; 2012 Mar; 33(3):628.e1-628.e14. PubMed ID: 21676498
[TBL] [Abstract][Full Text] [Related]
20. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.
Owen JB; Sultana R; Aluise CD; Erickson MA; Price TO; Bu G; Banks WA; Butterfield DA
Free Radic Biol Med; 2010 Dec; 49(11):1798-803. PubMed ID: 20869432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
